Computer-aided detection pioneer iCAD has upgraded its mammography CAD technology. The new product, Version 7.2, is now shipping with the company’s workstations SecondLook 300 and 700.
Computer-aided detection pioneer iCAD has upgraded its mammography CAD technology. The new product, Version 7.2, is now shipping with the company's workstations SecondLook 300 and 700.
"It is the latest algorithm that works across our product line," said Jeff Barnes, iCAD senior vice president of sales. "It is the only thing we are shipping now."
A variation of this version is designed for use on FujiFilm Medical USA's CR mammography product, Barnes noted. This particular software, optimized for CR, is still pending FDA approval, however.
CAD v7.2, like preceding versions, automatically identifies and marks areas of a digital mammogram. This latest software, however, has improved sensitivity to subtle cancers with fewer false positives and more understandable indications, according to Dr. Rachel Brem, an early evaluator of the software and director of breast imaging and intervention at the George Washington University Medical Center in Washington, DC.
The company claims CAD v7.2 reduces the number of false markings in SecondLook output. Brem reports that tests at GWU Medical Center showed a significant improvement in mass detection.
FDA Clears Updated AI Platform for Digital Breast Tomosynthesis
November 12th 2024Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.
Is the Kaiser Score More Effective than BI-RADS for Assessing Contrast-Enhanced Mammography and MRI?
October 14th 2024For women with breast-enhanced masses, Kaiser scoring (KS) demonstrated a 20 percent higher AUC than BI-RADS classification for contrast-enhanced mammography (CEM) and was comparable to KS for breast MRI.
FDA Clears New Features in AI-Powered Mammography Software Suite
October 11th 2024Therapixel’s MammoScreen suite has received 510(k) FDA clearances for a breast density assessment feature and updated software that includes automated pre-reporting, which reportedly expedites reporting of mammography findings.